Evidence map›Paper›PMID 23764352›Full record

ArticleInternational journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases2013

Incidence and predictors of severe anemia in Asian HIV-infected children using first-line antiretroviral therapy.

Torsak Bunupuradah, Azar Kariminia, Kwai-Cheng Chan, Reshmie Ramautarsing, Bui Vu Huy, Ning Han, Revathy Nallusamy, Rawiwan Hansudewechakul, Vonthanak Saphonn, Virat Sirisanthana and 9 more

Open access · goldAbstract read
In one paragraph

Article in International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed, 1 pooled it
0.9field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 1 synthesis or guideline pooled it, 23 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Maraviroc Population Pharmacokinetics Within the First 6 Weeks of Life.The Pediatric infectious disease journal · 2022
    Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors at 14 institutions in 8 countries.

Torsak BunupuradahHIV-NAT, the Thai Red Cross AIDS Research Center, 104 Ratchadamri Road, Pathumwan, Bangkok, Thailand 10330; Kirby Institute for Infection and Immunity in Society, UNSW, Sydney, Australia. Electronic address: torsak.b@hivnat.org.
Azar Kariminia
Kwai-Cheng Chan
Reshmie Ramautarsing
Bui Vu Huy
Ning Han
Revathy Nallusamy
Rawiwan Hansudewechakul
Vonthanak Saphonn
Virat Sirisanthana
Kulkanya Chokephaibulkit
Nia Kurniati
Nagalingeswaran Kumarasamy
Nik Khairulddin Nik Yusoff
Kamarul Razali
Siew Moy Fong
Annette H Sohn
Pagakrong Lumbiganon
TREAT Asia Pediatric HIV Observational Database
Hospital Pulau Pinang · MYAmsterdam UMC Location University of Amsterdam · NLBeijing Ditan Hospital · CNChiang Mai University · THChiangRai Prachanukroh Hospital · THHIV Netherlands Australia Thailand Research Collaboration · THHospital Kuala Lumpur · MYHospital Raja Perempuan Zainab II · MYKhon Kaen University · THNational Center for HIV/AIDS, Dermatology and STD · KHRumah Sakit Umum Pusat Nasional Dr. Cipto Mangunkusumo · IDSiriraj Hospital · THVietnam National Children's Hospital · VNYR Gaitonde Centre for AIDS Research and Education · IN

Funding

The Asia-Pacific HIV Research CollaborationU01AI069907 · NIAID · FOUNDATION FOR AIDS RESEARCH · PI ANNETTE H SOHN · 2006 to 2026
$44.8M
NIAID NIH HHS U01 AI069907NIAID NIH HHS U01AI069907
6 · The paper itself

Abstract

backgroundThere are limited data on treatment-related anemia in Asian HIV-infected children.

methodsData from Asian HIV-infected children aged <18 years on first-line highly active antiretroviral therapy (HAART) were used. Children who had pre-existing severe anemia at baseline were excluded. Anemia was graded using the United States Division of AIDS (DAIDS) 2004 table. Potential risk factors for severe anemia were assessed by logistic regression.

resultsData from 1648 children (51.9% female, 62.8% World Health Organization (WHO) stage 3/4) were analyzed. Median (interquartile range) age was 6.8 (3.7-9.6) years, CD4% was 9 (3-16)%, and plasma HIV-RNA was 5.2 (4.7-5.6) log10 copies/ml at HAART initiation in those with available testing. The most common regimens were stavudine/lamivudine/nevirapine (42%) and zidovudine/lamivudine/nevirapine (25%). Severe anemia was identified in 47 (2.9%) children after a median time of 6 months after HAART initiation, with an incidence rate of 5.4 per 100 child-years. Mild anemia or moderate anemia at baseline (p = 0.024 and p = 0.005, respectively), previous or current use of zidovudine (p < 0.0001 and p = 0.013, respectively), and male sex (p = 0.008) were associated with severe anemia. Higher weight-for-age z-score (p = 0.004) was protective.

conclusionsThe incidence of severe anemia in Asian HIV-infected children after HAART initiation was low and mainly occurred during the first few months after HAART initiation. Mild to moderate anemia at baseline and using zidovudine were independent risk factors for the development of severe anemia.

Indexed as

AnemiaAnti-HIV AgentsAntiretroviral Therapy, Highly ActiveAsia, SoutheasternChildChild, PreschoolFemaleHIV InfectionsHumansIncidenceIndiaKaplan-Meier EstimateMaleRisk FactorsTreatment OutcomeZidovudineAnti-HIV AgentsZidovudineAnemiaAntiretroviral therapyAsiaPediatric HIV

Identifiers

PMID23764352
PMCPMC4074526
OpenAlexW1968607461

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.